PharmaBoardroom Releases New Egypt Pharmaceuticals Report
Focus Reports releases its new 43 page Egypt Healthcare and Life Sciences Report 2016.
Accessible and sustainably financed healthcare is essential for the Egyptian people and critical to their prosperity and welfare, yet it is missing from Egypt today
LONDON, UNITED KINGDOM, May 17, 2016 /EINPresswire.com/ -- Focus Reports releases its new 43 page Egypt Healthcare and Life Sciences Report 2016.— Ahmed Emad El Din Rady, Minister of Health
This report offers companies, investors, policymakers, and stakeholders crucial insight into the largest pharmaceutical manufacturing base and the second largest pharmaceuticals market by value in the Middle East. Despite recent political upheaval, Egypt is a key growth market with massive unmet needs and huge potential for potential investors.
The report features a foreword from President Abdel Fattah El-Sisi, as well as an in-depth interview with Minister of Health Ahmed Emad El Din Rady. It also includes interview with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on the country’s healthcare and pharma sectors.
This report is an authoritative assessment of the Egyptian healthcare and pharma markets and covers:
Public Healthcare Reform
Minister of Health Ahmed Emad El Din Rady explains the direction that Egyptian healthcare will take over the next five years, highlighting four key areas for development: human capital development, accessibility, countering hepatitis C, and large-scale infrastructure development.
Egypt as a ‘Land of Opportunity’
Our 13 page cover story offers crucial insights into Egypt’s increasing political stability for investors, its evolving healthcare needs, Egyptian biotech, and the country’s positioning as a pharmaceutical hub for Africa.
Emerging Sectors
Interviews, features, and statistics on biosimilars, hospital supply, and nutraceuticals show that Egyptian healthcare and pharmaceuticals are multifaceted, as are the opportunities contained within them.
Interviews
The report includes interviews with:
Ahmed Emad El Din Rady, Minister of Health
Yasser Hefny, Hefny Pharma Group
Ramy Koussa, MSD Egypt
Amr Morsy, Rameda
Wafik Bardissi, Minapharm
Quotes
“We are aware of the underlying challenges ahead of us, but there is a clear intent and determination to put in every means to reach our objective to create a reliable system for a healthy society and promote the well-being of all Egyptians,”
Abdel Fattah El-Sisi, President of Egypt
“Accessible and sustainably financed healthcare is essential for the Egyptian people and critical to their prosperity and welfare, yet it is missing from Egypt today”
Ahmed Emad El Din Rady, Minister of Health
“Given the occurrence of shortages, we decided to expand our business and start importing and registering additional pharmaceutical products which have high demand to be manufactured locally”
Yasser Hefny, Hefny Pharma Group
“Public discussion of healthcare is dominated by communicable diseases, mainly Hepatitis C, yet the number of deaths derived from chronic illnesses and associated complications are actually much greater”
Mohamed El Dababy, Novo Nordisk
“Egypt ranks one of the top 3 markets in the region and accounts for some four to five billion USD… at current growth rates it should reach a significant volume threshold within the next few years and continue to attract sustained investments.”
Khaled Mansour, Janssen
Michael Comi
Focus Reports
+44 1707 828 754
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
